Clinical Trial

Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients

Name: Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients — clinical trial record (NCT07612163)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Patients may benefit from the personalized β-lactams dosing strategy based on pharmacokinetics. The objective of this study is to retrospectively review, prospective observe and analyze the clinical outcomes of patients with liver cirrhosis, and to build a population pharmacokinetics model in the population mentioned above.

Trial Details

NCT Number	NCT07612163
Lead Sponsor	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions	Bacterial Infections
Enrollment	1,000 participants
Start Date	2023-12-31
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-28